Spruce Biosciences, Inc.
- SPRB
- NASDAQ
- Biotechnology
- Biotech (Endocrine)
- Rare Disease Treatments
$39.99
Today +0.86%Quote Oct 19, 2026, 02:35 PM UTC
−26.38%over the last month
Max drawdown −27.6%From 1-month high −26.4%3 months −10.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$114.9M
Quote Oct 19
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$140.60
+251.6% from here
Floor
$39.98
0.0% below price
Where the price sits
11 analysts
Analyst range, low to high
$104.00$160.00
- Price $39.99
- Resistance $42.01
- Consensus $140.60
The price is just above its floor. Analysts' average target sits about 252% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SPRBPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
22
Founded
2014